Relias Media - Continuing Medical Education Publishing

The trusted source for

healthcare information and

CONTINUING EDUCATION.

  • Sign In
  • Sign Out
  • MyAHC
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    Home » C. diff: Colonization and Consequences

    C. diff: Colonization and Consequences

    One in 10 patients bring in C. diff through the front door

    February 1, 2020
    No Comments
    Reprints
    Facebook Twitter Linkedin Share Share

    Related Articles

    Unintended Consequences: Steps to Fight Sepsis Increase C. diff

    SHEA: Avoid Routine Testing for C. diff in the NICU

    IDWeek: Antibiotic Use in Dentistry Driving Up C. diff Rates

    Related Products

    Zika Questions Abound, but Standard Precautions Will Stop it

    Puerto Rico Bracing for Possible Zika Epidemic

    Preventing Sexual Transmission of Zika, Case in Dallas Prompts CDC guidelines

    Keywords

    antibiotics

    infection

    prevention

    colonized

    diff

    By: Gary Evans

    Although once thought of almost exclusively as a hospital-acquired condition, Clostridioides difficile has established a presence in the community that means about 10% of incoming patients could be carrying it asymptomatically, a new study finds.1

    Researchers tested 220 patients who showed no symptoms of C. diff infection when they were admitted between July 2017 and March 2018. Perirectal swabs were completed within 24 hours of admission, and the patients were followed for six months. Upon admission, 21 patients were identified as carriers.

    Within approximately six months, 38% percent of the asymptomatic carriers had developed full-blown C. diff infection — compared to just 2% of the noncarriers.

    The study raises difficult questions, not the least of which is, if you seek information are you compelled to act on it? Clearly these colonized patients are at some risk themselves and may serve as a reservoir for transmission to other patients. On the other hand, there is no clear path to decolonization, and putting more patients in contact isolation has adverse effects of its own.

    The lead author of the study, Sarah Baron, MD, MS, director of inpatient quality improvement at Montefiore Health System in New York City, spoke about the implications in an interview with Hospital Infection Control & Prevention.

    HIC: You show that asymptomatic C. diff carriers can go on to develop active disease after admission. If screening is done and this colonization state is known, what are some of the options and implications for infection prevention?

    Baron: I think for now we have a few ways to think about this. First of all, if screening was performed and we knew the colonization state of all patients, we could more carefully protect those patients who were not carriers. We could intensify our cleaning efforts to reduce spread, modify our isolation protocols, and educate the families. Infection prevention would carry some of the heaviest burden.

    For the population who are carriers, though — the patients who went on to have symptomatic C. difficile almost 40% of the time in our study — we really could tailor our treatment with even more antimicrobial stewardship and potentially prophylactic treatment for high-risk patients.

    In general, the knowledge that we would gain by identifying carriers might be an amazing opportunity to protect all of our patients, not only the carriers, from symptomatic infection.

    HIC: You note that the infection preventionists would bear a fair portion of the burden. What are the pros and cons of putting these patients in contact isolation?

    Baron: There are huge downsides to putting more patients in contact isolation, many of which I experience myself as a hospitalist caring for patients. The time and effort that it takes to appropriately put on personal protective equipment means that, amongst other things, patients get fewer visits or care from their care teams.

    We have seen this in multiple studies, and it truly can lead to suboptimal patient care, even as we all are trying to keep everyone safe. The question that many institutions are grappling with is how to minimize those downsides while maximizing the protection that isolation provides.

    HIC: Are there decolonization options for C. diff carriers?  

    Baron: As of now, I do not know of any decolonization options, although we may be able to prevent full symptomatic C. difficile infection, in some high-risk populations at least, with prophylactic antibiotics.

    HIC: Are you concerned that identifying colonized patients could encourage treatment or antibiotic use that may exacerbate their condition and lead to full-blown C. diff?

    Baron: Absolutely. This was one of the concerns even performing our study, which is why we did not notify providers that their patients were carriers — unless and until the providers requested C. diff testing. Alongside the ongoing research on C. diff prophylaxis, treatment, and prevention, we will need some pragmatic research on educating clinicians to not reflexively treat and isolate C. diff carriers as if they had symptomatic disease. As a physician working in the hospital, I know that this message will take time to permeate. I, myself, would have had a difficult time not treating a positive C. diff test result before I started working in this area.

    HIC: On the other hand, you note that knowing this colonized state enables clinicians to avoid using antibiotics known to disrupt the microbiome and set up C. diff infection.  

    Baron: Yes. One of the hallmarks of successful antimicrobial stewardship programs is the decrease in use of antibiotics, which have been associated most strongly with the development of C. diff. This work continues, of course, but has become more and more nuanced with time.

    Unfortunately, avoiding antibiotics is very difficult, as some of the antibiotics that we use to treat C. diff infections have been implicated in leading to more C. difficile infections — a tricky paradox. While all of us rely heavily on our colleagues in antimicrobial stewardship, I know that there also is work looking at innovative solutions to these issues, from more selective anti-C. diff antibiotics to oral beta-lactamases, which effectively might degrade any of our intravenous antibiotics that make it into the gastrointestinal tract and protect the microbiome. Screening for C. difficile carriage is one potentially useful step in our efforts towards C. difficile prevention, although certainly not the only option available.

    REFERENCE

    1. Baron S, Ostrowsky B, Nori P, et al. Screening of Clostridioides difficile carriers in an urban academic medical center: Understanding implications of disease. Infect Control Hosp Epidemiol 2019; Dec. 11. doi:10.1017/ice.2019.309. [Online ahead of print].

    Recent Articles by Gary Evans

    COVID-19 Mutations not Expected to Elude Vaccine

    Flu Vaccination Hesitancy in the Time of COVID-19

    Expert: Anti-Vaxxers Will Try to Undermine Pandemic Vaccine

    Post a comment to this article

    Report Abusive Comment

    www.reliasmedia.com

    Hospital Infection Control & Prevention

    View PDF
    Hospital Infection Control & Prevention (Vol. 47, No. 2) - February 2020
    February 1, 2020

    Table Of Contents

    Parents Can Pose Staph Risk to Babies in NICUs

    Is It Safe to Speak Up? Infection Prevention and ‘Psychological Safety’

    C. diff: Colonization and Consequences

    Antibiotic-Resistant Infections in Pediatrics

    Infectious Disease Update: Are You Looking for ESBLs?

    Healthcare Worker Attitudes About Respiratory Protection: It’s Complicated

    Begin Test

    Buy this Issue/Course

    Financial Disclosure: Peer Reviewer Patrick Joseph, MD, reports that he is a consultant for Genomic Health, Siemens, and CareDx. Senior Writer Gary Evans, Editor Jason Schneider, Editor Journey Roberts, Nurse Planner Patti Grant, RN, BSN, MS, CIC, and Editorial Group Manager Leslie Coplin report no consultant, stockholder, speaker’s bureau, research, or other financial relationships with companies having ties to this field of study.

    Shop Now: Search Products

    • Subscription Publications
    • Books & Study Guides
    • Webinars
    • Group & Site
      Licenses
    • State CME/CE
      Requirements

    Webinars And Events

    View All Events
    • Home
      • Home
      • Newsletters
      • Blogs
      • Archives
      • CME/CE Map
      • Shop
    • Emergency
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Hospital
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • Clinical
      • All Products
      • Publications
      • Study Guides
      • Webinars
      • Group Sales
    • All Access
      • Subscribe Now
      • My Subscription
    • My Account
      • My Subscriptions
      • My Content
      • My Orders
      • My CME/CE
      • My Transcript
    • Help
    • Search
    • About Us
    • Sign In
    • Register
    Relias Media - Continuing Medical Education Publishing

    The trusted source for

    healthcare information and

    CONTINUING EDUCATION.

    Customer Service

    customerservice@reliasmedia.com

    U.S. and Canada: 1-800-688-2421

    International +1-404-262-5476

    Accounts Receivable

    1-800-370-9210
    ReliasMedia_AR@reliasmedia.com

    Mailing Address

    • 1010 Sync St., Suite 100
      Morrisville, NC 27560-5468
      USA

    © 2020 Relias. All rights reserved.

    Do Not Sell My Personal Information  Privacy Policy  Terms of Use  Contact Us  Reprints  Group Sales

    For DSR inquiries or complaints, please reach out to Wes Vaux, Data Privacy Officer, DPO@relias.com

    Design, CMS, Hosting & Web Development :: ePublishing